Alan Reich
Endocrinology, Diabetes & Metabolism · Chicago, ILNPI 1932207487
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,212 and has fallen 74.8% since, to $558 in 2021.
Across 228 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$537
- Lilly USA, LLC$475
- AstraZeneca$419
- Sanofi-aventis U.S. LLC$344
- Johnson & Johnson$284
- Mannkind Corporation$266
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,96898%
- Education$291%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $537 |
| Lilly USA, LLC | 22 | $475 |
| AstraZeneca | 24 | $419 |
| Sanofi-aventis U.S. LLC | 18 | $344 |
| Johnson & Johnson | 14 | $284 |
| Mannkind Corporation | 14 | $266 |
| Boehringer Ingelheim | 11 | $214 |
| Merck | 13 | $205 |
| AbbVie | 9 | $169 |
| Corcept Therapeutics | 8 | $150 |
| Amgen(2 entities) | 6 | $108 |
| Amneal Pharmaceuticals LLC | 5 | $106 |
| Insulet Corporation | 4 | $95 |
| Valeritas, Inc. | 4 | $78 |
| Lifescan, Inc. | 4 | $76 |
| Dexcom, Inc. | 3 | $68 |
| Radius Health, Inc. | 3 | $68 |
| Shire North American Group Inc | 3 | $67 |
| Antares Pharma, Inc. | 3 | $59 |
| Tandem Diabetes Care, Inc. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| IBSA Pharma Inc. | 3 | $43 |
| Abbott | 3 | $41 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Aytu Biopharma, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Companion Medical, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$4,056 in reported general payments places this provider in the 75th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
See all endocrinology, diabetes & metabolism providers in Illinois →
Other endocrinology, diabetes & metabolism in Chicago
- Wahid KassarChicago$884K
- George BakrisChicago$403K
- Wenyu HuangChicago$341K
- Silvana PannainChicago$226K
- Grazia AleppoChicago$162K
- Tamara VokesChicago$139K
- Emily SmithChicago$112K
- Antonio BiancoChicago$111K
- Aaron BenjaminChicago$105K
- David OyerChicago$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.